Everolimus (RAD001, Afinitor)

Everolimus · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Everolimus (RAD001, Afinitor), covering 2013-03-06 to 2013-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma [Phase 2]